Written Question·Department of Health and Social Care·UIN 15868
Teplizumab
Tabled: 3 July 2026
Answered: 14 July 2026
Question
Cat Eccles
Labour — Stourbridge
To ask the Secretary of State for Health and Social Care, what steps he is taking to help ensure that the introduction of teplizumab contributes to reducing rates of diabetic ketoacidosis at diagnosis and inequalities in outcomes for people with type 1 di
Answer
Preet Kaur GillTeplizumab is a new treatment for people aged eight years old and over with stage 2 type 1 diabetes, before the onset of symptoms. Its introduction represents a significant development in the treatment of type 1 diabetes and requires new clinical pathways...
ⓘ
This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 15868) →